| 4 min read
Positive results in metabolic disease, a possible vaccine to treat the current Ebola outbreak, new cancer drug targets, and more led the news this week.
| 6 min read
Phase Advance is using mechanistic virtual patient models to predict how LEAF4Life's hypoxia-targeting therapy could perform across multiple indications.
| 3 min read
A new blood test focusing on KRAS mutations found evidence of pancreatic cancer recurrence before standard testing.
| 4 min read
Results from Johns Hopkins show a synthetic peptide vaccine was safe and activated mutant-KRAS-specific T cells in 90 percent of participants, offering an early signal that cancer interception may be possible before disease develops.
| 3 min read
Researchers find that infant airway tissue actively shapes the immune response to RSV, suggesting future therapies should target both the virus and inflammation.News
| 4 min read
A synthetic flavone restored vaginal tissue in a preclinical model, offering a potential nonsteroidal treatment for genitourinary syndrome of menopause.
| 4 min read
Psychedelic acquisitions, clinical trial updates, and more led the news this week.
| 5 min read
Aurion Biotech's manufacturing approach to unmodified allogeneic corneal endothelial cells offers a set of hard-won lessons for a cell therapy field still working out how to get from proof-of-concept to broad patient access.
| 3 min read
A new platform combines engineered viral vectors with the brain's glymphatic system to improve gene delivery to glial cells implicated in multiple neurological disorders.
| 3 min read
KCL-286 repaired neuronal DNA damage and reduced neuroinflammation in mice, with prior Phase 1 safety data potentially accelerating its path to Alzheimer's trials.
| 3 min read
Pediatric brain cancer is extremely challenging to treat. Results from a Phase 1 cell therapy trial revealed encouraging long-term survival rates.
Cancer Research News
Learn how patient-derived tumor organoids, AI, and phenotypic screening are advancing the discovery of small molecule therapeutics.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
Editor's Pick
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation.
Multimedia
Learn how developmental and reproductive toxicology study selection supports regulatory decision-making and generates meaningful nonclinical safety data.
Philip Wills, Chief Commercial Officer of the Cell & Gene Therapy Division at Catalent, reflects on how the gene therapy industry is evolving from early scientific breakthroughs to commercial maturity.
